Treatment with fludarabine and rituximab produces extended remissions and survival in chronic lymphocytic leukemia (CLL) without increased risk of second malignancy: Long-term follow up of CALGB study 9712
- Citation:
- Blood vol 114 (22) abstr 539
- Meeting Instance:
- ASH 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 144
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. Woyach N. A. Heerema A. Stark B. L. Peterson J. G. Gribben V. A. Morrison K. R. Rai R. A. Larson J. C. Byrd
- Networks:
- Study
- CALGB-9712
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: